Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Padron

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Placenta|January 25, 2014
Effect of pregestational diabetes mellitus on first trimester placental characteristics: three-dimensional placental volume and power Doppler indicesN L Gonzalez Gonzalez, E Gonzalez Davila, A Castro, et al.
The Journal of Pediatrics|December 5, 2008
Fetal and neonatal habituation in infants of diabetic mothersN L Gonzalez-Gonzalez, V Medina, E Padron, et al.
Leukemia|July 12, 2017
Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemiaQ Zhang, M C Ball, Y Zhao, et al.
Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
Leukemia|January 24, 2017
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research ConsortiumA M Zeidan, N Al Ali, J Barnard, et al.
Leukemia|October 31, 2015
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromesD A Sallman, R Komrokji, C Vaupel, et al.
Leukemia|March 28, 2013
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesM M Patnaik, E Padron, R R LaBorde, et al.
Blood Cancer Journal|August 1, 2015
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategiesE Padron, G Garcia-Manero, M M Patnaik, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Placenta|January 25, 2014
Effect of pregestational diabetes mellitus on first trimester placental characteristics: three-dimensional placental volume and power Doppler indicesN L Gonzalez Gonzalez, E Gonzalez Davila, A Castro, et al.
The Journal of Pediatrics|December 5, 2008
Fetal and neonatal habituation in infants of diabetic mothersN L Gonzalez-Gonzalez, V Medina, E Padron, et al.
Leukemia|July 12, 2017
Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemiaQ Zhang, M C Ball, Y Zhao, et al.
Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
Leukemia|January 24, 2017
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research ConsortiumA M Zeidan, N Al Ali, J Barnard, et al.
Leukemia|October 31, 2015
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromesD A Sallman, R Komrokji, C Vaupel, et al.
Leukemia|March 28, 2013
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesM M Patnaik, E Padron, R R LaBorde, et al.
Blood Cancer Journal|August 1, 2015
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategiesE Padron, G Garcia-Manero, M M Patnaik, et al.
Pageof 1